Form 4: OPKO Health Sells Shares of GeneDx Holdings Corp.
SEC Form 4 Filing
OPKO Health, a significant shareholder of GeneDx Holdings Corp., has sold a portion of its Class A Common Stock over three days in July 2024.
Summary
- OPKO Health, Inc. sold shares of GeneDx Holdings Corp. Class A Common Stock on July 1, 2, and 3, 2024.
- On July 1, 2024, 50,000 shares were sold at a weighted average price of $26.634.
- On July 2, 2024, 25,000 shares were sold at a weighted average price of $29.1238.
- On July 3, 2024, 14,082 shares were sold at a weighted average price of $28.2269.
- Following these transactions, OPKO Health directly owns 3,469,521 shares of GeneDx Holdings Corp. Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting share sales, indicating a neutral sentiment.
Industry Context
This activity is typical for major shareholders and is reported to the SEC to maintain transparency in the market.
Stakeholder Impact
- The share sales by OPKO Health could potentially influence the market price of GeneDx Holdings Corp.
Key Dates
| Date | Description |
|---|---|
| 07/01/2024 | OPKO Health sold 50,000 shares of GeneDx Holdings Corp. |
| 07/02/2024 | OPKO Health sold 25,000 shares of GeneDx Holdings Corp. |
| 07/03/2024 | OPKO Health sold 14,082 shares of GeneDx Holdings Corp. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.